(19)
(11) EP 3 261 455 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
16.02.2022 Bulletin 2022/07

(45) Mention of the grant of the patent:
26.01.2022 Bulletin 2022/04

(21) Application number: 16708198.3

(22) Date of filing: 19.02.2016
(51) International Patent Classification (IPC): 
A23L 2/60(2006.01)
(52) Cooperative Patent Classification (CPC):
A23L 2/60; A23L 33/125; A23L 29/30
(86) International application number:
PCT/GB2016/050422
(87) International publication number:
WO 2016/135458 (01.09.2016 Gazette 2016/35)

(54)

ALLULOSE SYRUPS

ALLULOSESIRUP

SIROPS D'ALLULOSE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 24.02.2015 US 201562120165 P
29.05.2015 US 201562168337 P

(43) Date of publication of application:
03.01.2018 Bulletin 2018/01

(60) Divisional application:
22150616.5

(73) Proprietors:
  • Tate & Lyle Ingredients Americas LLC
    Hoffman Estates, IL 60192 (US)
  • Tate & Lyle Technology Limited
    London WC2B 6AT (GB)

(72) Inventors:
  • WOODYER, Ryan D.
    Hoffman Estates, Illinois 60192 (US)
  • LLOYD-JONES, Peter
    Hoffman Estates, Illinois 60192 (US)

(74) Representative: Nieuwenhuys, William Francis 
Marks & Clerk LLP 15 Fetter Lane
London EC4A 1BW
London EC4A 1BW (GB)


(56) References cited: : 
US-A1- 2012 076 908
US-A1- 2014 271 747
 US-A1- 2014 271 746
US-A1- 2014 271 748
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).